14-day Premium Trial Subscription Sign Up For FreeGet Free

Adaptimmune Therapeutics plc Stock Forecast NASDAQ:ADAP

Price Target and Analyst Ratings

Most Recent Rating

On September 13, 2021 "Jonestrading" gave "$15.00" rating for ADAP. The price target was changed from $6.01 to 3.8%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-09-13 $15.00 Reiterated by Jonestrading $5.85 $6.01→3.8%
2021-09-13 $6.00 - $7.00 Target Raised by SVB Leerink $5.85 $6.03→3.5%
2021-09-09 $9.00 Initiated by Mizuho $6.21 $6.56+5.0%
2021-09-07 $5.00 - $6.00 Target Raised by SVB Leerink $6.37 $6.54+32.4%
2021-09-07 $15.00 Reiterated by Jonestrading $6.37 $6.45+30.6%
2021-08-10 $6.00 - $5.00 Target Lowered by SVB Leerink $3.57 $3.45→1.1%
2021-05-28 Underweight Initiated by Barclays $5.03 $4.00
2021-05-23 Hold Reiterated by SVB Leerink $5.09
2020-11-05 Market Perform Target Lowered by SVB Leerink $5.31 $10.00 → $6.00
2020-09-09 Equal Weight Initiated by Morgan Stanley $8.00 $42.00 → $42.00
2020-08-12 Overweight Initiated by Piper Sandler $7.91
2020-08-12 Overweight Initiated by Piper Sandler $7.91
2020-08-06 Market Perform Target Lowered by SVB Leerink $8.06 $11.00 → $10.00
2020-06-01 Neutral Target Raised by Mizuho $11.64 $3.00 → $9.00
2020-05-29 Hold Reiterated by Mizuho $11.07 $3.00
2020-04-27 Buy Target Lowered by Citigroup $3.40 $8.00 → $5.00
2020-04-21 Neutral Initiated by Mizuho $3.62 $3.00

ADAP Stock Trend

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled.

Given the current short-term trend, the stock is expected to rise 34.03% during the next 3 months and, with a 90% probability hold a price between $5.66 and $8.86 at the end of this 3-month period.

Data

Date Bottom Mid Top
2021-09-22 $4.25 $5.44 $6.64
2021-09-23 $4.28 $5.47 $6.66
2021-09-24 $4.30 $5.50 $6.69
2021-09-27 $4.33 $5.52 $6.72
2021-09-28 $4.36 $5.55 $6.74
2021-09-29 $4.38 $5.58 $6.77
2021-09-30 $4.41 $5.60 $6.80
2021-10-01 $4.44 $5.63 $6.82
2021-10-04 $4.46 $5.66 $6.85
2021-10-05 $4.49 $5.68 $6.88
2021-10-06 $4.52 $5.71 $6.90
2021-10-07 $4.54 $5.74 $6.93
2021-10-08 $4.57 $5.76 $6.96
2021-10-11 $4.60 $5.79 $6.98
2021-10-12 $4.62 $5.82 $7.01
2021-10-13 $4.65 $5.84 $7.04
2021-10-14 $4.68 $5.87 $7.06
2021-10-15 $4.70 $5.90 $7.09
2021-10-18 $4.73 $5.92 $7.12
2021-10-19 $4.76 $5.95 $7.14
2021-10-20 $4.78 $5.98 $7.17
2021-10-21 $4.81 $6.00 $7.20
2021-10-22 $4.84 $6.03 $7.22
2021-10-25 $4.86 $6.06 $7.25
2021-10-26 $4.89 $6.08 $7.28
2021-10-27 $4.92 $6.11 $7.30
2021-10-28 $4.94 $6.14 $7.33
2021-10-29 $4.97 $6.16 $7.36
2021-11-01 $4.99 $6.19 $7.38
2021-11-02 $5.02 $6.22 $7.41

About Adaptimmune Therapeutics plc

Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on the provision of cancer immunotherapy products based on its T-cell receptor platform. Its platform enables to identify cancer targets; find and genetically engineer T-cell receptors (TCR); and produce TCR therapeutic candidates for administration to patients. The company’s lead program includes NY-ESO cancer antigen, which is in Phase 1/2 clinical trials for the... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT